Recent Updates
Recently added Catalysts
NMTC Positive Sentiment Score: 70/100

NeuroOne to Present at the Sidoti Micro-Cap Virtual Conference on May 10

Key Takeaway: NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) has announced that CFO Ron McClurg will present at the Sidoti Micro-Cap Virtual Conference on May 10-11, 2023. The presentation aims to highlight the company's advancements in medical technology targeting neurological disorders. Investors are encouraged to request one-on-one meetings during the conference.

Market Sentiment Analysis

POSITIVE FACTORS

  • CFO Ron McClurg's presentation may attract investor interest.
  • Focus on innovative technologies for neurological disorders.
  • Opportunity to engage with investors during the virtual conference.

Full Press Release Details

EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that CFO Ron McClurg will present at the Sidoti Micro-Cap Virtual Conference being held May 10-11, 2023.
Presentation date: Wednesday, May 10, 2023
Presentation time: 10:45 a.m.*
Registration: sidoti.com/events
Live presentation: Session link
1x1 meetings: Investors may request meetings by contacting their Sidoti representative or NeuroOne Investor Relations .
*Please note that the presentation date and time are subject to change. Attendees may refer to the program agenda for more information.
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.
*Caution: Federal law restricts this device to sale by or on the order of a physician.

Tags

NeuroOne Medical Technologies
medical technology company
Sidoti Micro-Cap Virtual

Frequently Asked Questions

What is NeuroOne Medical Technologies focused on?

NeuroOne focuses on enhancing surgical care for patients with neurological disorders.

When will NeuroOne's CFO present at the Sidoti Conference?

CFO Ron McClurg's presentation is scheduled for May 10, 2023, at 10:45 a.m.

Where can I find more information on NeuroOne?

More details about NeuroOne can be found at their website nmtc1.com.

What types of conditions does NeuroOne address?

NeuroOne addresses epilepsy, Parkinson's disease, chronic pain, and more.

How can investors schedule meetings with NeuroOne?

Investors can request meetings through their Sidoti representative or NeuroOne IR.

Last updated: May 5, 2023